Effect of growth hormone treatment on the adult height of children with chronic renal failure
Children with chronic renal failure are at high risk for growth retardation and decreased adult height.1 Therapy with recombinant human growth hormone increases the growth rate and improves the standardized height (height expressed as the number of standard deviations from normal height) in prepuber...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 28, 2000
|
| In: |
The New England journal of medicine
Year: 2000, Volume: 343, Issue: 13, Pages: 923-930 |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJM200009283431304 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1056/NEJM200009283431304
|
| Author Notes: | Dieter Haffner, Franz Schaefer, Richard Nissel, Elke Wühl, Burkhard Tönshoff, Otto Mehls |
| Summary: | Children with chronic renal failure are at high risk for growth retardation and decreased adult height.1 Therapy with recombinant human growth hormone increases the growth rate and improves the standardized height (height expressed as the number of standard deviations from normal height) in prepubertal children with chronic renal failure.2,3 However, whether the final height is improved by this treatment is unknown. In children with growth hormone deficiency or idiopathic short stature, it has been suspected that growth hormone accelerates the onset or progression of puberty, thereby neutralizing the effect of any treatment-induced acceleration of prepubertal growth on adult height. . . . |
|---|---|
| Item Description: | Gesehen am 12.01.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1533-4406 |
| DOI: | 10.1056/NEJM200009283431304 |